Comparing stent treatments for chronic mesenteric ischemia
Official title: Copenhagen Mesenteric Stent Study - A Randomized Trial of Stent Versus Covered Stent Treatment for Chronic Mesenteric Ischemia
Run by Copenhagen University Hospital, Rigshospitalet · NCT05244629 · Data updated 2026-11-12
This study is testing whether covered stents work better than bare metal stents for people with chronic mesenteric ischemia to see which one helps them more after a year.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 98 (estimated) |
| Sponsor | Copenhagen University Hospital, Rigshospitalet Academic / other |
| Locations | 1 site (København Ø) |
| Status | Recruiting |
| Started | June 2023 |
| Main results expected | August 2024 |
| Study ends | August 2029 |
| Registry record updated | June 12, 2023 |
| Trial ID | NCT05244629 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults over 18 with symptomatic chronic mesenteric ischemia due to significant atherosclerotic stenosis.
✕Probably not a fit
Patients with non-atherosclerotic causes of mesenteric ischemia or those experiencing acute mesenteric ischemia will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This trial evaluates the effectiveness of bare metal stents (BMS) versus covered stents (CS) in treating chronic mesenteric ischemia (CMI), a condition caused by narrowed arteries supplying blood to the intestines. Patients with significant stenosis of the superior mesenteric artery will be randomly assigned to receive either type of stent. The primary outcome measured will be stent patency one year after placement, along with assessments of complications, reoperation rates, quality of life, and mortality reasons. The study aims to provide clearer evidence on the benefits of using covered stents over bare stents.
Why it matters
Potential benefit: If successful, this study could lead to improved treatment options for patients with chronic mesenteric ischemia, potentially reducing symptoms and recurrence rates.
How similar studies have gone: While the use of covered stents is increasingly supported, the level of evidence is limited, indicating that this approach is still being evaluated.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with symptomatic CMI of atherosclerotic or atherothrombotic etiology * Intended endovascular treatment * Symptoms consistent with CMI (pain, weight loss, diarrhea) * Significant ostial stenosis (\>50%) of the superior mesenteric artery on CTA * Significant stenosis on angiography (\>50% or \>15mmHg pressure gradient) * Patients \> 18 years Exclusion Criteria: * No informed consent * Non atherosclerotic cause of MI * Acute mesenteric ischemia (AMI) * Signs of acute bowel ischemia, peritonitis, laparotomy, sepsis * Previous stent treatment in the superior mesenteric artery(ies) * Target artery lesions \>4cm in length * Unable to cross lesion with guidewire * Non-significant stenosis angiographically * Pregnancy * Allergies to contrast media or stent materials
Where it's running
-
Department of Vascular Surgery, Heart Center, Copenhagen University Hospital - Rigshospitalet
København Ø, Denmark Recruiting
Study contacts
- Principal investigator: Timothy A Resch, MD, PhD — Deptarment of Vascular Surgery, Rigshospitalet
- Study coordinator: Timothy A Resch, MD, PhD
- Email: timothy.andrew.resch@regionh.dk
- Phone: +45 35 45 79 31
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Photon-counting CT to check intracranial stents
This study tests whether ultra-high-resolution photon-counting CT can reliably visualize intracranial stents and detect in-stent restenosis during follow-up of patients with prior stents.
-
Guselkumab vs Ustekinumab for stricturing Crohn's disease
This study will follow adults with moderate-to-severe Crohn's disease and confirmed intestinal strictures to see if treatment with guselkumab or ustekinumab better controls obstructive symptoms and disease activity.
-
Apixaban with or without Clopidogrel in stroke patients with NVAF and intracranial/extracranial atherosclerosis
This study tests whether adding clopidogrel to apixaban is safe and helpful for people with acute ischemic stroke due to non-valvular atrial fibrillation and atherosclerosis.
-
Comparing mini-crush and controlled balloon-crush techniques for treating coronary bifurcation lesions
This study is testing whether two different stenting techniques, mini-crush and controlled balloon-crush, work better for treating complex heart artery blockages in people with coronary bifurcation lesions.
-
Comparing OCT guidance to angiography for treating coronary in-stent restenosis
This study is testing whether using a special imaging technique called OCT can help treat patients with blocked heart stents better than the usual method of using angiography.
-
Using fluorescence to assess bowel health during emergency surgery
This study is testing if a special dye can help surgeons see if the bowel is healthy during emergency surgery for patients with suspected bowel problems, to see if it leads to better outcomes and fewer follow-up surgeries.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.